What is Imalac?
Imalac specializes in developing advanced breastfeeding support products, most notably its Nurture Breast Massager. This hands-free device is engineered to assist nursing mothers by enhancing milk supply and mitigating common breastfeeding challenges such as clogged ducts and mastitis. The product aims to increase the efficiency of breast pumping, enabling mothers to express more milk in a shorter period. Imalac targets both breastfeeding mothers and healthcare professionals, fostering a supportive ecosystem with resources designed to help users achieve their breastfeeding objectives. The company's commitment lies in delivering stylish, functional products that elevate the overall breastfeeding experience.
How much funding has Imalac raised?
Imalac has raised a total of $70K across 1 funding round:
Debt
$70K
Debt (2021): $70K with participation from PPP
What's next for Imalac?
With significant Series B/C stage backing, Imalac is poised for accelerated growth and market penetration. The recent substantial expansion capital will likely be directed towards scaling production, enhancing product development, and broadening its market reach. This strategic investment signals confidence in Imalac's innovative approach to maternal health technology and its potential to capture a larger share of the growing femtech market. Future initiatives may include expanding the product line, forging new strategic partnerships, and increasing marketing efforts to reach a wider audience of nursing mothers and healthcare providers.
See full Imalac company page
